| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2362.2006.01649.X |
| P698 | PubMed publication ID | 16684123 |
| P2093 | author name string | Kriwanek S | |
| Schernthaner G | |||
| Schernthaner GH | |||
| Koppensteiner R | |||
| Kopp HP | |||
| Krzyzanowska K | |||
| P2860 | cites work | CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells | Q24310570 |
| Reduction of atherosclerosis in mice by inhibition of CD40 signalling | Q24316540 | ||
| Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 | ||
| Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus | Q28194498 | ||
| Meta-analysis: surgical treatment of obesity | Q28243512 | ||
| Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery | Q29614192 | ||
| CD40-CD40L interactions in atherosclerosis | Q34498144 | ||
| Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice | Q35160907 | ||
| CD40 ligation induces tissue factor expression in human vascular smooth muscle cells | Q35793488 | ||
| Platelet activation and the CD40/CD40 ligand pathway: mechanisms and implications for human disease | Q36161310 | ||
| Atherosclerosis: the emerging role of inflammation and the CD40-CD40 ligand system | Q36216095 | ||
| CD154/CD40-mediated expression of CD154 in endothelial cells: consequences for endothelial cell-monocyte interaction | Q40587639 | ||
| Platelet activation in obese women: role of inflammation and oxidant stress | Q44184883 | ||
| Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapy | Q44283435 | ||
| Effects of obesity and weight loss on soluble CD40L levels | Q44396151 | ||
| Effect of Rosiglitazone Treatment on Soluble CD40L in Patients With Type 2 Diabetes and Coronary Artery Disease | Q44403568 | ||
| Impact of Weight Loss on Inflammatory Proteins and Their Association With the Insulin Resistance Syndrome in Morbidly Obese Patients | Q44417114 | ||
| Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study | Q44606908 | ||
| Weight loss reduces circulating asymmetrical dimethylarginine concentrations in morbidly obese women | Q45173678 | ||
| Early activation of vascular endothelial cells and platelets in obese children | Q45310730 | ||
| Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women. | Q46511139 | ||
| Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: results from the Dallas Heart Study | Q46658441 | ||
| Effect of atorvastatin on circulating proinflammatory T-lymphocyte subsets and soluble CD40 ligand in patients with stable coronary artery disease--a randomized, placebo-controlled study | Q46861411 | ||
| Effects of rosiglitazone alone and in combination with atorvastatin on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus | Q46954084 | ||
| Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture? | Q52527039 | ||
| The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. | Q52962713 | ||
| The effect of age on the association between body-mass index and mortality. | Q55067309 | ||
| Soluble CD40 Ligand in Acute Coronary Syndromes | Q58816350 | ||
| Soluble CD40L and Cardiovascular Risk in Asymptomatic Low-Grade Carotid Stenosis | Q59536411 | ||
| A comparison between BMI and Conicity index on predicting coronary heart disease: the Framingham Heart Study | Q73039202 | ||
| Influence of obesity on cardiovascular risk. Twenty-three-year follow-up of 22,025 men from an urban Swedish population | Q74466067 | ||
| Platelet-derived CD40L: the switch-hitting player of cardiovascular disease | Q74627856 | ||
| Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes | Q78108701 | ||
| Soluble CD40 ligand levels indicate lipid accumulation in carotid atheroma: an in vivo study with high-resolution MRI | Q78780749 | ||
| P433 | issue | 6 | |
| P921 | main subject | obesity | Q12174 |
| morbid obesity | Q9051491 | ||
| P304 | page(s) | 395-401 | |
| P577 | publication date | 2006-06-01 | |
| P1433 | published in | European Journal of Clinical Investigation | Q15745208 |
| P1476 | title | Soluble CD40L in patients with morbid obesity: significant reduction after bariatric surgery. | |
| P478 | volume | 36 |
| Q84742760 | A clinical cardiology perspective of thrombophilias |
| Q33768652 | Acute suppression of circulating sCD40L during hyperglycemia and euglycemic-hyperinsulinemia in healthy young males |
| Q37413941 | Assessment of serum levels of soluble CD40L in Egyptian children and adolescents with type 1 diabetes mellitus: Relationship to microalbuminuria and glycemic control |
| Q36790184 | Cure of type 2 diabetes by metabolic surgery? A critical analysis of the evidence in 2010. |
| Q37639541 | Decreased Levels of Circulating Cancer-Associated Protein Biomarkers Following Bariatric Surgery. |
| Q46116943 | Duodenal-Jejunal bypass improves glucose homeostasis in association with decreased proinflammatory response and activation of JNK in the liver and adipose tissue in a T2DM rat model |
| Q64885446 | Early-onset obesity and the unwanted promise of thrombosis. |
| Q35138237 | Emerging markers of atherosclerosis before and after bariatric surgery |
| Q47270963 | Heterozygosity for the rs696217 SNP in the Preproghrelin Gene Predicts Weight Loss After Bariatric Surgery in Severely Obese Individuals. |
| Q28078518 | Multiple Sclerosis and Obesity: Possible Roles of Adipokines |
| Q37313752 | Obesity and inflammation: lessons from bariatric surgery |
| Q34278709 | Obesity related alterations in plasma cytokines and metabolic hormones in chimpanzees |
| Q22250939 | Obesity, Inflammation, and Insulin Resistance |
| Q37932076 | Platelet activation in obesity and metabolic syndrome |
| Q35735264 | Soluble CD40 Ligand in Aspirin-Treated Patients Undergoing Cardiac Catheterization |
| Q38838093 | The impact of bariatric surgery on inflammation: quenching the fire of obesity? |
| Q34020389 | The levels of soluble CD40 ligand and C-reactive protein in normal weight, overweight and obese people |
| Q90600162 | [Association between CD40-CD40L system and obesity in children] |
Search more.